Chirravuri Leeladhar - Cambridge Technology Chief Officer
| CTE Stock | 41.51 0.26 0.63% |
Executive
Chirravuri Leeladhar is Chief Officer of Cambridge Technology Enterprises
| Address | Capital Park, Hyderabad, India, 500081 |
| Phone | 91 40 6723 4400 |
| Web | https://www.ctepl.com |
Cambridge Technology Management Efficiency
The company has return on total asset (ROA) of (0.1119) % which means that it has lost $0.1119 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5328) %, meaning that it generated substantial loss on money invested by shareholders. Cambridge Technology's management efficiency ratios could be used to measure how well Cambridge Technology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cambridge Technology's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 401.1 M, whereas Non Current Assets Total are forecasted to decline to about 560.8 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sreenath Reddy | Aster DM Healthcare | 50 | |
| Lars Atorf | Procter Gamble Health | N/A | |
| Veneeth Purushotaman | Aster DM Healthcare | N/A | |
| Saurabh Paliwal | Aster DM Healthcare | N/A | |
| Sonu Goyal | Yatharth Hospital Trauma | N/A | |
| Niralkumar Zota | Zota Health Care | 47 | |
| Hitesh Dhaddha | Aster DM Healthcare | 42 | |
| Shilpi Singh | Yatharth Hospital Trauma | N/A | |
| Rekha Bijoykumar | Procter Gamble Health | N/A | |
| Dalia Aziz | Aster DM Healthcare | 53 | |
| Brandon Rowberry | Aster DM Healthcare | N/A | |
| Nitish Shetty | Aster DM Healthcare | 52 | |
| Malathi Arshanapalai | Aster DM Healthcare | 71 | |
| Nandish Joshi | Zydus Wellness Limited | N/A | |
| Rahul Kadavakolu | Aster DM Healthcare | N/A | |
| Trilok Saini | Silgo Retail Limited | N/A | |
| Hemakumar Nemmali | Aster DM Healthcare | N/A | |
| Sunil Punjabi | Procter Gamble Health | N/A | |
| Pritpal Singh | Aster DM Healthcare | N/A | |
| Viral Mandviwala | Zota Health Care | 49 | |
| Vishal Naik | Procter Gamble Health | N/A | |
Management Performance
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.11 |
Cambridge Technology Leadership Team
Elected by the shareholders, the Cambridge Technology's board of directors comprises two types of representatives: Cambridge Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cambridge. The board's role is to monitor Cambridge Technology's management team and ensure that shareholders' interests are well served. Cambridge Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cambridge Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tangella Prasad, Chief Officer | ||
| Raghavan Madabhushi, Executive President | ||
| Swaroop Dharani, Whole Director | ||
| Purnayya Puppala, Chief Officer | ||
| Padmanava Debnath, Associate Technology | ||
| Priyanka Chugh, Company Officer | ||
| Sudip Kar, USA Inc | ||
| Sanjiv Nathwani, USA Inc | ||
| Chirravuri Leeladhar, Chief Officer | ||
| GVS Kumar, Company Officer | ||
| Nitin Tyagi, Senior Solutions | ||
| Gopi Vemuri, Senior President | ||
| Dharani Swaroop, Whole Director | ||
| Ashish Bhattad, Company Officer | ||
| Riaz Mohammad, Director Delivery |
Cambridge Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cambridge Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 1.64 B | ||||
| Shares Outstanding | 19.25 M | ||||
| Shares Owned By Insiders | 66.26 % | ||||
| Price To Book | 1.17 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 1.99 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cambridge Stock
Cambridge Technology financial ratios help investors to determine whether Cambridge Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cambridge with respect to the benefits of owning Cambridge Technology security.